Detailed Description
Elizium is suitable for relieving: sneezing, nasal discharge, itching, swelling and nasal congestion, itching and redness of the eyes, tearing, itching in the palate area, and coughing, if they are related to allergic rhinitis, as well as itching and rashes associated with urticaria¹.
Elizium in tablet form is recommended for children aged 12 and older.¹
Elizium has anti-inflammatory and anti-allergic effects¹, which allow it to relieve symptoms of allergic rhinitis and urticaria.
Elizium is advisable when there is a need to relieve symptoms of allergic rhinitis and urticaria. According to international guidelines,2-4 for chronic urticaria and allergic rhinitis, non-sedating antihistamines of the second generation, such as desloratadine (Elizium), are considered first-line treatment.
Elizium can be used throughout the entire period of exposure to the allergen.¹
Elizium oral solution and tablets are available at pharmacies without a prescription.
In the Elizium oral solution packaging, there are two dosing devices: a measuring spoon and a syringe – this allows you to choose a convenient method of administration for yourself and your child.
Elizium is your choice if you need to relieve symptoms of allergic rhinitis or urticaria.
How to use:
| Patient Age | Daily dose and frequency of administration |
| Children aged 1-5 years | 2.5 ml of solution (1.25 mg desloratadine) once a day |
| Children aged 6-11 years | 5 ml of solution (2.5 mg desloratadine) once a day |
| Children aged 12 years and older, and adults | 10 ml of solution / 1 tablet (5 mg desloratadine) once a day |
Elizium – allergie* has minimal chances!
*The term “allergy” refers to symptoms associated with allergic rhinitis (sneezing, nasal discharge, itching, swelling and nasal congestion, itching and redness of the eyes, tearing, itching in the palate area, and coughing) and urticaria (itching, rashes).
**After determining the individual reaction to the medicinal product (according to the package leaflet of the Elizium medicinal product).
- According to the package leaflet of the Elizium medicinal product.
- Zuberbier T, Aberer W, Asero R et al. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2018 Jul;73(7):1393-1414.
- Brożek JL, Bousquet J, Agache I et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017 Oct;140(4):950-958.
- Seidman MD, Gurgel RK, Lin SY, Schwartz SR, Baroody FM, Bonner JR, et al. Clinical practice guideline: Allergic rhinitis. Otolaryngol Head Neck Surg 2015; 152:S1-43.
Reviews
There are no reviews yet.